new targeted therapy options for er positive, her2 negative, advanced breast cancer
Published 1 month ago • 669 plays • Length 21:57Download video MP4
Download video MP3
Similar videos
-
15:00
new fda-approved targeted drug for treatment-resistant, er positive her2 negative breast cancer
-
7:44
treatment options for her2 breast cancer: a comprehensive guide
-
31:21
novel therapeutics for breast cancer: her2 and triple negative disease; new pathways, targets
-
34:12
new and emerging agents in her2-negative metastatic breast cancer: implications for practice
-
25:14
metastatic her2 negative breast cancer: emerging novel treatment strategies
-
3:12
treatments for hr , her2-negative metastatic breast cancer
-
3:19
study of targeted therapy for her2-positive metastatic breast cancer
-
5:37
how to treat her2-positive (her2 ) breast cancer: all you need to know
-
7:13
treatment options for er/pr positive or negative breast cancer
-
2:43
sequencing treatment options in her2 positive breast cancer: 2023 best of breast conference
-
3:58
promise breast cancer clinical trial
-
0:59
sequencing her2-targeted therapies in breast cancer
-
4:09
selecting her2-targeted therapy for early breast cancer
-
1:35:31
leveraging targeted therapies to improve outcomes across the continuum of her2 breast cancer
-
1:38
genomic assays for chemotherapy decisions in er-positive/her2-negative breast cancer
-
1:31
current treatment options for patients with her2-positive metastatic breast cancer
-
56:54
10/16/2015: "evolution of targeted therapies in breast cancer: new opportunities for cure"
-
3:22
managing recurrent metastatic er /her2- breast cancer
-
1:25:42
hormone receptor-positive advanced breast cancer: challenges and new treatment options